Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Quest Laboratories Ltd

Pharmaceuticals & Biotechnology | Small Cap

Quest Laboratories Ltd Health Insights
Health Score : 5.27Health Score : 5.27

Quest Laboratories demonstrates a mixed financial performance. Profitability stands out as a significant strength, driven by healthy margins and returns on capital, equity, and assets. Solvency also appears strong, indicating a conservative approach to debt. However, the company faces challenges in liquidity and efficiency, with turnover ratios suggesting potential issues in managing assets and liabilities. Growth metrics reveal a concerning contraction in revenue, EPS, and asset growth in the latest financial year. While coverage ratios are adequate, the absence of dividend coverage raises concerns. The company's strong profitability and solvency are offset by liquidity and efficiency issues. The recent negative growth trends in revenue and earnings are a significant concern that needs attention.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Quest Laboratories Ltd Health Insights
Health Score : 5.27Health Score : 5.27

Quest Laboratories demonstrates a mixed financial performance. Profitability stands out as a significant strength, driven by healthy margins and returns on capital, equity, and assets. Solvency also appears strong, indicating a conservative approach to debt. However, the company faces challenges in liquidity and efficiency, with turnover ratios suggesting potential issues in managing assets and liabilities. Growth metrics reveal a concerning contraction in revenue, EPS, and asset growth in the latest financial year. While coverage ratios are adequate, the absence of dividend coverage raises concerns. The company's strong profitability and solvency are offset by liquidity and efficiency issues. The recent negative growth trends in revenue and earnings are a significant concern that needs attention.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

11.22

Undervalued

Industry Median

28.62

Undervalued
Undervalued

Small Cap Median

27.17

Undervalued

P/E RATIO

11.21

P/B RATIO

1.74

Undervalued

Industry Median

3.17

Undervalued
Undervalued

Small Cap Median

2.62

Undervalued

P/S RATIO

1.49

Undervalued

Industry Median

3.42

Undervalued
Undervalued

Small Cap Median

2.55

Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Undervalued

EV/EBITDA RATIO

7.97

Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹102.8 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 3.20

Growth metrics indicate significant challenges for Quest Laboratories, with declines in revenue, EPS, and asset growth. Strong operating profit growth is overshadowed by these contractions. The company needs to address the factors causing these declines to ensure sustainable growth and maintain its competitive position.

PoorRevenue Growth RatePoor
ExcellentOperating Profit Growth RateExcellent
PoorEarnings Per Share (EPS) GrowthPoor
PoorAsset Growth RatePoor
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate96.675.0833.8725.37.69
Operating Profit Growth Rate50033.33100012.5
Earnings Per Share (EPS) Growth-2.0110.75
Asset Growth Rate94.4434.2929.79100-9.02
Net Income Growth Rate30025100407.14
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.00

Financial metrics present a mixed picture for Quest Laboratories. While capital expenditures are well-managed, earnings per share and book value per share are weak. The absence of dividends further impacts the overall assessment. The company needs to focus on improving earnings and enhancing shareholder value to strengthen its financial position.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
ExcellentCapital Expenditures (CapEx)Excellent
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)40.2508.338.759.38
Cash Earnings Per Share (Cash EPS)40609.179.3810
Book Value Per Share10015024.1750.6260
Dividend Per Share (DPS)000
Capital Expenditures (CapEx)1.930.93.55.2
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

Profitability metrics demonstrate exceptional performance for Quest Laboratories, with strong margins and returns on capital, equity, and assets. This indicates efficient operations and effective management. The company excels in generating profits from its investments and sales, providing a solid foundation for sustainable growth and financial stability.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin10.1711.2918.0714.4215.18
Return on Capital Employed (ROCE)5547572718
Return on Equity (ROE)4033.3334.4817.2815.62
Return on Assets (ROA)17.1417.0226.2313.1116.22
Operating Margin10.1712.919.2815.3816.07
Net Margin6.788.0612.0513.4613.39
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 5.33

Efficiency metrics reveal a mixed performance for Quest Laboratories. While inventory management appears strong, concerns arise from fixed asset and capital turnover. Receivable management also poses challenges. The company excels in inventory management but needs to improve the utilization of its fixed assets and overall capital to enhance operational efficiency.

WeakFixed Asset Turnover RatioWeak
GoodInventory Turnover RatioGood
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
AverageReceivable DaysAverage
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio8.436.28.38.677.47
Inventory Turnover Ratio55.218.984.994.753.17
Receivables Turnover Ratio3.782.953.743.823.38
Days Sales in Inventory Ratio6.6140.6573.1576.84115.14
Receivable Days96.56123.7397.5995.55107.99
Capital Turnover Ratio5.23.672.781.261.16
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 5.60

Coverage ratios are mixed, with adequate interest coverage offset by the absence of dividend coverage. This suggests that Quest Laboratories can comfortably meet its interest obligations but does not provide returns to equity holders through dividends. While interest coverage is solid, the lack of dividend payments may deter potential investors.

GoodInterest Coverage RatioGood
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage RatioN/A8152010
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 9.00

Quest Laboratories showcases exceptional solvency, with a strong position across debt and equity metrics. This indicates a conservative and stable financial structure. The company has very low debt levels relative to equity and assets, highlighting financial stability and a reduced risk of financial distress. This robust solvency provides a solid foundation for future growth and resilience against economic uncertainties.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
AverageEquity RatioAverage
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.120.110.030.020.01
Debt to Equity Ratio0.140.120.030.020.01
Equity Ratio0.880.890.970.980.99
Debt To Asset Ratio0.040.040.010.010.01
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 3.08

Liquidity position is a concern for Quest Laboratories, with a mix of weak and below-average scores across key metrics. The company may face difficulties in meeting its short-term obligations. While the current and quick ratios are low, the minimal cash ratio and operating cash flow ratio further highlight potential liquidity strains. This situation could restrict the company's operational flexibility and its ability to capitalize on immediate growth opportunities.

PoorCurrent RatioPoor
WeakQuick RatioWeak
PoorCash RatioPoor
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.131.221.411.496.09
Quick Ratio1.090.860.890.943.11
Cash Ratio0.070000.01
Operating Cash Flow Ratio0.130.130.1-0.59-0.85
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 7 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Par Drugs & Chemicals Ltd7.408.88Undervalued17.0010.6513.00
2Vaishali Pharma Ltd6.74103.62Overvalued4.000.314.00
3Quest Laboratories Ltd5.2711.21Neutral18.009.1615.00
4Sotac Pharmaceuticals Ltd5.2721.26Neutral18.004.456.00
5Zenith Drugs Ltd4.637.52Neutral17.002.3010.00
6Krebs Biochemicals & Industries Ltd4.16-5.27Highly Undervalued-4.00-12.49-4.00
Management Assessment Summary
OrangeBalanced Management

The management of Quest Laboratories demonstrates a mixed performance. The company has shown strong growth in sales and maintains high ROCE and ROE. However, increasing borrowings and a fluctuating cash conversion cycle present concerns. A substantial promoter holding indicates confidence, but the recent investment in assets requires monitoring for optimal returns. Overall, management effectiveness is rated as mixed due to these counterbalancing factors.

Category Metric Value Assessment
PROS Strong Sales Growth 26% Sales expansion is robust.
High ROCE and ROE 57.48%, 46.15% Capital and shareholder funds are yielding good returns.
CONS Increasing Short Term Borrowings ₹ 28.89 Cr. Leverage is increasing.
Fluctuating Cash Conversion Cycle 3 to 178 Days Working capital management is inconsistent.
GoodFinancial Performance & GrowthGood
ExcellentCapital Efficiency & ReturnsExcellent
AverageFinancial Health & PrudenceAverage
GoodShareholding & Ownership StructureGood
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
OrangeBalanced Risk

Quest Laboratories faces a moderate risk profile. The increase in short-term borrowings raises concerns about financial leverage. The fluctuating cash conversion cycle suggests potential inefficiencies in working capital management. The lack of dividend payouts might deter some investors. These factors contribute to an overall risk assessment that requires careful monitoring.

WeakOff-balance sheet exposure quantificationWeak
WeakContingent liability evaluationWeak
WeakAccounting quality red flagsWeak
WeakSegment performance volatilityWeak
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Accounting quality red flags

04.

Segment performance volatility

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10105.41Bearish
  3. SMA 20110.23Bearish
  4. SMA 50105.58Bearish
  5. EMA 10105.25Bearish
  6. EMA 20106.93Bearish
  7. EMA 50106.54Bearish
  8. DEMA 10102.46Bearish
  9. DEMA 20105.80Bearish
  10. DEMA 50107.46Bearish
  11. TEMA 10101.20Bullish
  12. TEMA 20103.17Bearish
  13. TEMA 50108.90Bearish
  14. MACD-1.28Bearish
  15. ADX27.01Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI36.63Neutral
  3. CCI-104.78Oversold
  4. ROC 9-4.32Bearish
  5. ROC 14-12.82Bearish
  6. ROC 25-3.41Bearish
  7. Stoch K7.28Oversold
  8. Stoch D5.36Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper122.16Neutral
  3. BB Middle110.23Neutral
  4. BB Lower98.31Neutral
  5. ATR2.23Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI20.18Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10108.08Bearish
  3. SMA 20107.78Bearish
  4. SMA 50104.06Bearish
  5. EMA 10106.30Bearish
  6. EMA 20106.72Bearish
  7. EMA 50106.52Bearish
  8. DEMA 10104.42Bearish
  9. DEMA 20107.35Bearish
  10. DEMA 50104.86Bearish
  11. TEMA 10102.00Bullish
  12. TEMA 20106.63Bearish
  13. TEMA 50107.17Bearish
  14. MACD0.11Bearish
  15. ADX24.19Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI41.42Neutral
  3. CCI-76.80Neutral
  4. ROC 9-12.82Bearish
  5. ROC 14-5.77Bearish
  6. ROC 25-0.20Bearish
  7. Stoch K10.46Oversold
  8. Stoch D18.52Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper120.03Neutral
  3. BB Middle107.78Neutral
  4. BB Lower95.54Neutral
  5. ATR3.19Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI38.94Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 10107.47Bearish
  3. SMA 20104.11Bearish
  4. SMA 50107.37Bearish
  5. EMA 10106.32Bearish
  6. EMA 20105.93Bearish
  7. EMA 50108.63Bearish
  8. DEMA 10106.89Bearish
  9. DEMA 20105.58Bearish
  10. DEMA 50103.53Bearish
  11. TEMA 10106.26Bearish
  12. TEMA 20107.72Bearish
  13. TEMA 50N/AN/A
  14. MACD-0.04Bullish
  15. ADX23.52Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI44.34Neutral
  3. CCI-24.59Neutral
  4. ROC 91.90Bullish
  5. ROC 142.00Bullish
  6. ROC 251.39Bullish
  7. Stoch K30.40Neutral
  8. Stoch D39.40Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper114.91Neutral
  3. BB Middle104.11Neutral
  4. BB Lower93.32Neutral
  5. ATR4.58Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI75.82Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 10104.14Bearish
  3. SMA 20106.37Bearish
  4. SMA 50115.91Bearish
  5. SMA 100113.59Bearish
  6. SMA 200103.68Bearish
  7. EMA 10106.01Bearish
  8. EMA 20107.40Bearish
  9. EMA 50111.31Bearish
  10. EMA 100110.81Bearish
  11. EMA 200108.39Bearish
  12. DEMA 10106.14Bearish
  13. DEMA 20103.48Bearish
  14. DEMA 50109.02Bearish
  15. DEMA 100114.21Bearish
  16. DEMA 200109.54Bearish
  17. TEMA 10108.17Bearish
  18. TEMA 20103.75Bearish
  19. TEMA 50103.95Bearish
  20. TEMA 100113.46Bearish
  21. TEMA 200N/AN/A
  22. MACD-2.53Bullish
  23. ADX15.25Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI44.30Neutral
  3. CCI-26.94Neutral
  4. ROC 140.64Bullish
  5. ROC 25-7.01Bearish
  6. Stoch K47.92Neutral
  7. Stoch D53.25Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper120.70Neutral
  3. BB Middle106.37Neutral
  4. BB Lower92.03Neutral
  5. ATR6.72High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI70.03Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 20114.99Bearish
  3. SMA 50103.31Bearish
  4. EMA 20112.27Bearish
  5. EMA 50109.02Bearish
  6. DEMA 20116.02Bearish
  7. DEMA 50109.38Bearish
  8. TEMA 20115.05Bearish
  9. TEMA 50N/AN/A
  10. MACD2.08Bearish
  11. ADX26.12Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI47.32Neutral
  3. CCI-17.07Neutral
  4. ROC 14-8.30Bearish
  5. ROC 25-7.08Bearish
  6. Stoch K14.07Oversold
  7. Stoch D18.08Oversold
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper140.43Neutral
  3. BB Middle114.99Neutral
  4. BB Lower89.55Neutral
  5. ATR13.87Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI53.54Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

No results for this timeframe.

No results for this timeframe

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 6117.13Bearish
  3. SMA 12105.45Bullish
  4. SMA 24112.48Bullish
  5. EMA 6117.85Bearish
  6. EMA 12112.92Bullish
  7. EMA 24112.95Bullish
  8. DEMA 6125.71Bearish
  9. DEMA 12116.24Bullish
  10. DEMA 24N/AN/A
  11. TEMA 6129.36Bearish
  12. TEMA 12N/AN/A
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADXN/AN/A
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSIN/AN/A
  3. CCIN/AN/A
  4. ROC 25N/AN/A
  5. ROC 50N/AN/A
  6. Stoch KN/AN/A
  7. Stoch DN/AN/A
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper144.01Neutral
  3. BB Middle108.89Neutral
  4. BB Lower73.76Neutral
  5. ATR30.39High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.99Neutral